Vistagen Therapeutics (VTGN) Selling, General & Administrative (2011 - 2026)
Vistagen Therapeutics (VTGN) reported Selling, General & Administrative of $3.92 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 10.3% from $4.37 million a year earlier and down 4.9% from the prior quarter.
Vistagen Therapeutics (VTGN) Selling, General & Administrative (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vistagen Therapeutics' Selling, General & Administrative came in at $18.06 million, up 7.0% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $18.42 million, up 7.8% from FY2025.
- Selling, General & Administrative has a five-year compound annual growth rate of 21.0% (FY2021 to FY2026).
- By fiscal year, Selling, General & Administrative came in at $17.08 million in FY2025 (+21.5%), $14.06 million in FY2024 (-4.1%), $14.66 million in FY2023 (+8.8%) and $13.48 million in FY2022 (+89.9%).
- The fiscal Q1 2027 figure ranks as the lowest quarterly Selling, General & Administrative since fiscal Q3 2024.
- Year over year, Selling, General & Administrative gained in five of the last eight quarters, with growth averaging 8.5%.
- The high point for year-over-year Selling, General & Administrative in five years was fiscal Q4 2022 (growth of 154.1%); the low point was fiscal Q1 2024 (a decline of 37.9%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $4.12 million (Q4 2026), $5.63 million (Q3 2026) and $4.4 million (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Vistagen Therapeutics | 12.43 Mn | 12.43 Mn | - | 3.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.92 Mn |
| Mar 31, 2026 | 4.12 Mn |
| Dec 31, 2025 | 5.63 Mn |
| Sep 30, 2025 | 4.40 Mn |
| Jun 30, 2025 | 4.37 Mn |
| Mar 31, 2025 | 4.27 Mn |
| Dec 31, 2024 | 4.05 Mn |
| Sep 30, 2024 | 4.20 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Mar 31, 2024 | 4.12 Mn |
| Dec 31, 2023 | 3.76 Mn |
| Sep 30, 2023 | 3.21 Mn |
| Jun 30, 2023 | 2.98 Mn |
| Mar 31, 2023 | 3.08 Mn |
| Dec 31, 2022 | 3.09 Mn |
| Sep 30, 2022 | 3.70 Mn |
| Jun 30, 2022 | 4.79 Mn |
| Mar 31, 2022 | 4.50 Mn |
| Dec 31, 2021 | 3.12 Mn |
| Sep 30, 2021 | 3.22 Mn |
Vistagen Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();